Danaher Stock News

According to the new market research report "Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region - Global Forecasts to 2026", published by MarketsandMarkets,

James Investment Research Inc. raised its stake in shares of Danaher Co. (NYSE:DHR) by 66.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 19,187 shares of the conglomerates stock after buying an additional 7,640 shares during the period. James Investment Research Inc.s holdings in Danaher were []

Trust Co. of Vermont reduced its holdings in shares of Danaher Co. (NYSE:DHR) by 1.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,934 shares of the conglomerates stock after selling 315 shares during the period. Trust Co. of Vermonts holdings in Danaher []

Great Diamond Partners LLC bought a new stake in Danaher Co. (NYSE:DHR) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,401 shares of the conglomerates stock, valued at approximately $426,000. Several other hedge funds and other institutional investors have also recently []

Danaher Co. (NYSE:DHR) announced a quarterly dividend on Tuesday, December 7th, RTT News reports. Shareholders of record on Thursday, December 30th will be paid a dividend of 0.21 per share by the conglomerate on Friday, January 28th. This represents a $0.84 dividend on an annualized basis and a yield of 0.27%. Danaher has increased its []

Farmers & Merchants Investments Inc. decreased its position in Danaher Co. (NYSE:DHR) by 0.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 44,137 shares of the conglomerates stock after selling 418 shares during the quarter. Farmers & Merchants Investments Inc.s holdings in []

Townsend Asset Management Corp NC ADV lifted its stake in shares of Danaher Co. (NYSE:DHR) by 0.7% during the third quarter, Holdings Channel reports. The fund owned 16,393 shares of the conglomerates stock after acquiring an additional 120 shares during the period. Danaher comprises 2.7% of Townsend Asset Management Corp NC ADVs investment portfolio, making []

Boenning & Scattergood Inc. decreased its position in shares of Danaher Co. (NYSE:DHR) by 2.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,354 shares of the conglomerates stock after selling 336 shares during the period. Boenning & Scattergood Inc.s holdings []

LS Investment Advisors LLC lowered its position in shares of Danaher Co. (NYSE:DHR) by 1.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 98,654 shares of the conglomerates stock after selling 1,726 shares during the period. Danaher accounts for approximately 3.9% []

Sound View Wealth Advisors Group LLC boosted its holdings in Danaher Co. (NYSE:DHR) by 30.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,232 shares of the conglomerates stock after purchasing an additional 521 shares during the period. Sound View Wealth Advisors []

The Cytotoxicity assays measure the loss of some cellular or intercellular structure and/or functions, counting lethal cytotoxicity. They thus give a suggestion of the possibility to cause cell and matter injury and as such has been used by some detectives

According to the new market research report "Flow Cytometry Market by Product (Analyzer, Sorter, Reagents, Consumables, Software), Technology, Application (Research, Clinical - Cancer Diagnostics, Hematology), End User (Academia, Research Labs, Pharma, Biotech, Hospitals) - Global Forecast to 2026", published by

Pune , India , 2021-Dec-07 /EPR Network/ The global In-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from [read full press release]

Diamant Asset Management Inc. acquired a new position in shares of Danaher Co. (NYSE:DHR) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,775 shares of the conglomerates stock, valued at approximately $845,000. A number of other institutional investors have also recently added to []

Brown Miller Wealth Management LLC increased its holdings in shares of Danaher Co. (NYSE:DHR) by 5.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,533 shares of the conglomerates stock after purchasing an additional 179 shares during the quarter. []